85 related articles for article (PubMed ID: 6726433)
1. Malignant pheochromocytoma treated by I-131 MIBG.
McDougall IR
J Nucl Med; 1984 Feb; 25(2):249-51. PubMed ID: 6726433
[No Abstract] [Full Text] [Related]
2. [Use of I-131-meta-iodobenzylguanidine in the treatment of malignant pheochromocytoma. Description of 2 cases].
Jakubowski W; Feltynowski T; Woy-Wojciechowski J; Leowska E; Liziniewicz A
Pol Tyg Lek; 1986 Oct; 41(43):1386-8. PubMed ID: 3822916
[No Abstract] [Full Text] [Related]
3. [Therapy of malignant pheochromocytoma using I-131 metaiodobenzylguanidine--report of a case].
Okazawa H; Endo K; Saga T; Watanabe Y; Nakai T; Kasagi K; Konishi J; Abe M; Goto K; Nakao K
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Mar; 50(3):286-94. PubMed ID: 2345700
[TBL] [Abstract][Full Text] [Related]
4. Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG.
Nakabeppu Y; Nakajo M
Ann Nucl Med; 1994 Nov; 8(4):259-68. PubMed ID: 7702971
[TBL] [Abstract][Full Text] [Related]
5. Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytoma.
Lewington VJ; Zivanovic MA; Tristam M; McEwan AJ; Ackery DM
J Nucl Biol Med (1991); 1991; 35(4):280-3. PubMed ID: 1823836
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic possibilities in metastatic pheochromocytoma].
Vierhapper H; Raber W
Zentralbl Chir; 1997; 122(6):494-7. PubMed ID: 9334119
[TBL] [Abstract][Full Text] [Related]
7. Radiopharmaceutical treatment of malignant pheochromocytoma.
Sisson JC; Shapiro B; Beierwaltes WH; Glowniak JV; Nakajo M; Mangner TJ; Carey JE; Swanson DP; Copp JE; Satterlee WG
J Nucl Med; 1984 Feb; 25(2):197-206. PubMed ID: 6726430
[TBL] [Abstract][Full Text] [Related]
8. (131)I-MIBG treatment of pheochromocytoma: low versus intermediate activity regimens of therapy.
Castellani MR; Seghezzi S; Chiesa C; Aliberti GL; Maccauro M; Seregni E; Orunesu E; Luksch R; Bombardieri E
Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):100-13. PubMed ID: 20168292
[TBL] [Abstract][Full Text] [Related]
9. The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
Shapiro B; Sisson JC; Shulkin BL; Gross MD; Zempel S
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):55-7. PubMed ID: 9002750
[TBL] [Abstract][Full Text] [Related]
10. Horizons in radionuclide therapy: 1985 update.
Beierwaltes WH
J Nucl Med; 1985 Apr; 26(4):421-7. PubMed ID: 3884750
[TBL] [Abstract][Full Text] [Related]
11. A case of malignant pheochromocytoma treated by 131I-metaiodobenzylguanidine.
Theilade K; Bak M; Olsen K; Nielsen SL; Christensen NJ
Acta Oncol; 1988; 27(3):296-7. PubMed ID: 3415861
[No Abstract] [Full Text] [Related]
12. Radionuclide therapy of pheochromocytomas and neuroblastomas using iodine-131 metaiodobenzylguanidine (MIBG).
Brendel AJ; Jeandot R; Guyot M; Lambert B; Drouillard J
Clin Nucl Med; 1989 Jan; 14(1):19-21. PubMed ID: 2714036
[No Abstract] [Full Text] [Related]
13. Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma.
Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C
J Clin Endocrinol Metab; 1991 Feb; 72(2):455-61. PubMed ID: 1991814
[TBL] [Abstract][Full Text] [Related]
14. [Radioisotope therapy of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine--absorbed dose assessments using SPECT].
Aritake S
Kaku Igaku; 1992 Jun; 29(6):667-78. PubMed ID: 1640651
[TBL] [Abstract][Full Text] [Related]
15. Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytoma.
Blake GM; Lewington VJ; Fleming JS; Zivanovic MA; Ackery DM
Eur J Nucl Med; 1988; 14(7-8):345-8. PubMed ID: 3181183
[TBL] [Abstract][Full Text] [Related]
16. Nuclear medicine therapy of pheochromocytoma and paraganglioma.
Troncone L; Rufini V
Q J Nucl Med; 1999 Dec; 43(4):344-55. PubMed ID: 10731785
[TBL] [Abstract][Full Text] [Related]
17. Treatment of malignant pheochromocytoma with a new radiopharmaceutical.
Sisson J; Shapiro B; Beierwaltes WH; Nakajo M; Glowniak J; Mangner T; Carey JE; Swanson DP; Copp J; Satterlee W
Trans Assoc Am Physicians; 1983; 96():209-17. PubMed ID: 6679954
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effectiveness of 131I-MIBG on malignant pheochromocytoma--results of long-term follow-up].
Kusakabe K; Kanaya K; Kanaya S; Yazaki E; Nakano K; Matsumoto N; Kobayashi H; Maki M; Itou Y; Obara T
Kaku Igaku; 1994 Dec; 31(12):1495-502. PubMed ID: 7861648
[TBL] [Abstract][Full Text] [Related]
19. [A case of malignant pheochromocytoma treated with 131I-metaiodobenzylguanidine and CVD regimen].
Ukimura O; Kojima M; Hosoi S; Itoh H; Watanabe H; Minamikawa T
Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):811-4. PubMed ID: 8022145
[TBL] [Abstract][Full Text] [Related]
20. Aspects on radionuclide therapy in malignant pheochromocytomas.
Forssell-Aronsson E; Bernhardt P; Wängberg B; Kölby L; Nilsson O; Ahlman H
Ann N Y Acad Sci; 2006 Aug; 1073():498-504. PubMed ID: 17102117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
